Bionano Genomics, Inc.
| Security | BNGO / Bionano Genomics, Inc. |
| Insider | Mark Borodkin |
This page shows the track record and history of Borodkin Mark
insider trades in Bionano Genomics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Mark Borodkin in BNGO / Bionano Genomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2018-08-23 | 815 | 6.1250 | 23 | 214.3750 | 4,992 | 35 | 82.5 | -3,094 | -61.98 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Mark Borodkin in BNGO / Bionano Genomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-03 | 2025-06-03 | 4 | Borodkin Mark | BNGO | Common Stock | D | 3.6900 | -27 | -0 | 974 | ||||
| 2025-02-19 | 2025-02-15 | 4 | Borodkin Mark | BNGO | Common Stock | D | 5.7300 | -20 | -0 | 1,001 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Borodkin Mark | BNGO | Common Stock | D | 0.4800 | -3,568 | -2 | 61,283 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Borodkin Mark | BNGO | Common Stock | D | 16,000 | 64,698 | ||||||
| 2024-03-05 | 2024-02-15 | 4 | Borodkin Mark | BNGO | Common Stock | D | 1.2700 | -1,229 | -2 | 48,644 | ||||
| 2023-09-20 | 2023-09-18 | 4 | Borodkin Mark | BNGO | Common Stock | D | 20,000 | 317,842 | ||||||
| 2023-05-16 | 2023-05-12 | 4 | Borodkin Mark | BNGO | Common Stock | D | 0.6600 | -41,496 | -27 | 297,842 | ||||
| 2023-02-17 | 2023-02-15 | 4 | Borodkin Mark | BNGO | Common Stock | D | 120,000 | 339,338 | ||||||
| 2022-05-16 | 2022-05-12 | 4 | Borodkin Mark | BNGO | Common Stock | D | 1.4100 | -41,496 | -59 | 216,669 | ||||
| 2022-02-15 | 2022-02-15 | 4 | Borodkin Mark | BNGO | Stock Option (Right to Buy) | D | 2.18 | 650,000 | 650,000 | |||||
| 2021-05-14 | 2021-05-12 | 4 | Borodkin Mark | BNGO | Common Stock | D | 240,000 | 252,086 | ||||||
| 2021-04-02 | 2021-04-01 | 4 | Borodkin Mark | BNGO | Stock Option (Right to Buy) | D | 7.83 | 275,000 | 275,000 | |||||
| 2020-03-06 | 2019-03-01 | 4 | Borodkin Mark | BNGO | Stock Option (Right to Buy) | D | 4.25 | 60,000 | 60,000 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Borodkin Mark | BNGO | Stock Option (Right to Buy) | D | 1.04 | 120,000 | 120,000 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Borodkin Mark | BNGO | Stock Option (Right to Buy) | D | 1.30 | -6,000 | 28,219 | |||||
| 2019-01-22 | 2019-01-18 | 4 | Borodkin Mark | BNGO | Common Stock | D | 1.3000 | 6,000 | 8 | 6,815 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Borodkin Mark | BNGO | Stock Option (Right to Buy) | D | 7.77 | 59,590 | 59,590 | |||||
| 2018-08-27 | 2018-08-23 | 4 | Borodkin Mark | BNGO | Common Stock Warrants (right to buy) | D | 6.12 | 815 | 815 | |||||
| 2018-08-27 | 2018-08-23 | 4 | Borodkin Mark | BNGO | Common Stock | D | 6.1250 | 815 | 5 | 815 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
